The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
Verywell Health on MSN1d
A New FDA-Approved Antibiotic May Help Women With Recurring UTIsIf you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...
Everyday Health on MSN5d
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 YearsKey TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes. Study participants were ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.
Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback